Literature DB >> 21666727

Perspective: recognizing resistance.

Diana Sylvestre1.   

Abstract

Mesh:

Year:  2011        PMID: 21666727     DOI: 10.1038/474S11a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  5 in total

1.  Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy.

Authors:  N Singh; S M Berman; S Swindells; J C Justis; J A Mohr; C Squier; M M Wagener
Journal:  Clin Infect Dis       Date:  1999-10       Impact factor: 9.079

2.  Mutations conferring resistance to SCH6, a novel hepatitis C virus NS3/4A protease inhibitor. Reduced RNA replication fitness and partial rescue by second-site mutations.

Authors:  MinKyung Yi; Xiao Tong; Angela Skelton; Robert Chase; Tong Chen; Andrew Prongay; Stephane L Bogen; Anil K Saksena; F George Njoroge; Ronald L Veselenak; Richard B Pyles; Nigel Bourne; Bruce A Malcolm; Stanley M Lemon
Journal:  J Biol Chem       Date:  2005-12-13       Impact factor: 5.157

3.  Adherence to isoniazid prophylaxis in the homeless: a randomized controlled trial.

Authors:  J P Tulsky; L Pilote; J A Hahn; A J Zolopa; M Burke; M Chesney; A R Moss
Journal:  Arch Intern Med       Date:  2000-03-13

4.  Psychiatric morbidity, illicit drug use and adherence to zidovudine (AZT) among injection drug users with HIV disease.

Authors:  S J Ferrando; T L Wall; S L Batki; J L Sorensen
Journal:  Am J Drug Alcohol Abuse       Date:  1996-11       Impact factor: 3.829

5.  Characterization of resistance mutations against HCV ketoamide protease inhibitors.

Authors:  Xiao Tong; Stephane Bogen; Robert Chase; V Girijavallabhan; Zhuyan Guo; F George Njoroge; Andrew Prongay; Anil Saksena; Angela Skelton; Ellen Xia; Robert Ralston
Journal:  Antiviral Res       Date:  2007-12-28       Impact factor: 5.970

  5 in total
  1 in total

Review 1.  Hepatitis C virus: a new class of virus associated with particles derived from very low-density lipoproteins.

Authors:  Jin Ye
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-05       Impact factor: 8.311

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.